Oncofusion

start / graph / gene-aqr

Genemoderate confidence 3 of 5: One strong study, or several smaller consistent ones.king

AQR (Aquarius) - a spliceosomal RNA helicase whose loss impairs MLL-rearranged leukaemia stem cells

also called Aquarius · IBP160 · intron-binding protein 160 · O60306

AQR is a motor protein that helps cells cut the non-coding pieces out of freshly made RNA. It turned up as part of a newly described machine that links reading a gene to processing its RNA, and removing it badly damages the stem-like cells that keep KMT2A-rearranged leukaemia going.

The same thing, for a scientist

AQR is an intron-binding RNA helicase of the spliceosomal IBC. Native chromatin proteomics places it in ECAS, a bipartite promoter-proximal assembly joining an AFF4-ELL2-EAF1 elongation module to a U2 snRNP-associated intron binding complex, and reported as molecularly DISTINCT from canonical P-TEFb-containing SEC. Acute AQR/XAB2 perturbation impairs productive gene-body elongation without altering pause release, increases intron retention and preferentially affects long genes; in mouse haematopoietic cells Aqr perturbation impairs leukaemia initiation, maintenance and leukaemia stem cell function in MLL-rearranged leukaemia.

What it looks like
loading AF-O60306-F1…
AlphaFold AF-O60306-F1 ↗
colourshape

This is a prediction, not a measurement. No one has seen this protein in this shape. The colours say how much the software trusts itself, and that is worth reading before anything else — the orange stretches are places the model is effectively saying this part has no fixed shape.

very high (90+)confident (70–90)low (50–70)very low (<50)
I have never read one of these pictures before

A protein is one long chain of amino acids that folds up. The ribbon traces that chain from one end to the other; it is not a wire, it is a simplification of where the backbone runs. Drag to rotate, scroll to zoom.

Domains are the stretches of chain that do a particular job, and they are what the coloured blocks above the picture mark out. Click one and the view flies to it. In this project the important question about any domain is usually whether the fusion still has it — the labels say lost where it does not.

Anything in yellow sticks is a bound small molecule, which is usually the drug.

Go deeper
Why this matters here: a second ELL2-containing complex that is not SEC

This graph treats ELL2 and AFF4 as super elongation complex subunits, and the hijack model routes the fusion's effect through SEC. ECAS is reported as molecularly distinct from canonical P-TEFb-containing SEC while containing AFF4 and ELL2. If that holds, then 'AFF4/ELL2 is present' stops being sufficient evidence that SEC is the relevant assembly, and some existing composition claims are underdetermined.

The mechanism is also unusual in a way that matters for this project. AQR loss impairs productive gene-body elongation without altering pause release. Nearly every elongation-directed hypothesis in this graph is framed around pause release, because that is what CDK9 and P-TEFb do. A requirement that acts after pause release, preferentially on long genes, is a different lever.

What it does NOT establish

It is not an ELL2 result. The leukaemia dependency demonstrated is AQR's. ELL2 appears as a module member of ECAS, and no ELL2-specific requirement in KMT2A-fusion leukaemia is reported. That distinction is the whole point of the reopening condition attached to ELL2 in this graph, and it is not met.

A spliceosomal helicase is a hard target. AQR is core splicing machinery. The space between 'leukaemia stem cells need it' and 'normal haematopoiesis does not' is exactly where this class of target usually fails, and the abstract reports no such window.

Nuclear speckles and promoter-proximal chromatin (Q87, 2026-09-21)

Subcellular. Nucleus - UniProt O60306 carries four coded experimental citations for it, unusually well supported for this tranche. HPA v25.1 IF, reliability Enhanced: nucleoplasm, single main location. No cytoplasmic pool in either source.

Subnuclear, and there are two. (1) Nuclear speckles - AQR/IBP160 depletion releases MALAT-1 from speckles into the nucleoplasm (PMID 22355166), which is what UniProt's uncoded 'speckle-like regions' note rests on. (2) Promoter-proximal chromatin, as part of ECAS with AFF4-ELL2-EAF1 (PMID 42748909).

Why the second matters here. AFF4 and ELL2 are core to this graph's elongation axis, so AQR's chromatin address places it directly beside the machinery KMT2A fusions hijack - and ECAS is reported as distinct from the canonical P-TEFb-containing SEC.

Cell state. Productive gene-body elongation, not pause release: acute AQR/XAB2 perturbation impairs elongation without altering pause release, increases intron retention and preferentially affects long genes.

Cell type. No AQR localisation experiment exists in any haematopoietic cell; the mouse leukaemia result this entry already carries is functional.

Facts and figures
uniprotO60306
gene symbolAQR
length AA1485
protein nameRNA helicase aquarius
alphafold IDAF-O60306-F1
accession resolutiongene_exact:AQR + reviewed:true; primary gene name read back as AQR; UniProt entry AQR_HUMAN; 2026-09-19
complexECAS (elongation complex associated with splicing); spliceosomal intron binding complex
acts onproductive gene-body elongation and co-transcriptional RNA processing
shown for fusionNo. Reported for MLL-rearranged leukaemia in mouse haematopoietic cells; the fusion partner is not named in the abstract and no KMT2A::AFF1-specific result is claimed.
why newSurfaced on 2026-09-19 by scripts/watch-reopening-conditions.py as the only actionable hit against ELL2's reopening condition. It does not satisfy that condition, but it introduces a dependency the graph did not have.
subnuclear localizationNUCLEAR SPECKLES and PROMOTER-PROXIMAL CHROMATIN. AQR (as IBP160) is one of the nuclear speckle proteins whose depletion releases MALAT-1 from speckles into the nucleoplasm (PMID 22355166), which is the observation behind UniProt O60306's uncoded 'speckle-like regions of the nucleoplasm' note; and native chromatin proteomics places AQR in ECAS, a promoter-proximal chromatin-occupying assembly linking an AFF4-ELL2-EAF1 elongation module to a U2 snRNP-associated intron binding complex (PMID 42748909). AFF4 and ELL2 are core members of this graph's elongation axis, so the chromatin address puts AQR directly adjacent to the machinery KMT2A fusions hijack.
cell statePRODUCTIVE ELONGATION versus PAUSING is the state AQR acts on, and the distinction is sharp: acute perturbation of AQR/XAB2-dependent ECAS functions impairs productive gene-body elongation WITHOUT altering pause release, increases intron retention, preferentially affects long genes, reduces capping-factor recruitment and nascent 5' capping, and increases promoter-proximal accumulation. That is a defined transcriptional state rather than a cell-identity label, and it is the state this graph's whole elongation argument is about.
depmap selectivity scan
{
  "rank": 17654,
  "of": 17728,
  "percentile": 99.583,
  "difference": 0.2438,
  "pan_essentiality_all_lines": -1.1488,
  "partner_XAB2": {
    "rank": 17704,
    "percentile": 99.865,
    "difference": 0.3243,
    "pan_essentiality_all_lines": -2.311
  },
  "direction": "LESS required in KMT2A-rearranged lines than in other leukaemia lines",
  "reference_ranks": {
    "MEN1": 1,
    "KMT2A": 11,
    "MEIS1": 84,
    "AFF1": 160,
    "DOT1L": 184,
    "USP22": 226
  },
  "run_date": "2026-09-19",
  "verdict": "Answers this entry's own open question with a negative. Does not refute the published LSC result, which DepMap cannot measure, but removes the free supporting evidence that was hoped for."
}
depmap kmt2a selectivity
{
  "chronos_mean_kmt2a_rearranged": -1.0182,
  "chronos_mean_other_leukaemia": -1.262,
  "difference": 0.2438,
  "pan_essentiality_all_lines": -1.1488,
  "selectivity_rank": 17654,
  "rank_denominator": 17728,
  "provenance": "Joined 2026-09-21 from analyses/depmap-kmt2a-selective-scan-full (generated 2026-09-19T10:12:06Z), the project's own genome-wide scan over 11 KMT2A-rearranged and 43 other leukaemia DepMap lines. NOT re-fetched and NOT independent of that scan: every caveat it carries applies here, including that the KMT2A-rearranged arm is a small number of lines drawn from nine individuals, that the rank denominator is 17,728 genes, and that a difference is not a dependency. Added because only 26 of 308 gene entries carried this number, which made any KMT2A-selectivity question answerable for 8% of the corpus.",
  "how_to_read": "A negative difference means MORE required in KMT2A-rearranged lines than in other leukaemia lines. A rank near 17,728 is ANTI-selective. Neither is evidence of a fusion-driven dependency on its own: check pan_essentiality_all_lines before calling anything selective, and note that a paralogue-redundant gene can score near zero for reasons that have nothing to do with this disease - see ana-the-paralogue-redundancy-excuse-is-not-tested-and-my-proxy-decided-the-answer."
}
localization
{
  "subcellular": "NUCLEUS. UniProt O60306 lists Nucleus on FOUR coded experimental citations (ECO:0000269 PubMed:11991638, 25599396, 28076346, 28502770) and Nucleus/nucleoplasm on a fifth (PubMed:16949364), with the uncoded note 'Localizes to speckle-like regions of the nucleoplasm'. HPA v25.1 IF, reliability Enhanced, gives a single main location, Nucleoplasm. No cytoplasmic pool is recorded by either source.",
  "subnuclear": "TWO addresses, and the second is the one that matters for this graph. (1) NUCLEAR SPECKLES: AQR is named as one of the nuclear speckle proteins - with RNPS1 and SRm160 - whose RNAi depletion causes MALAT-1 noncoding RNA to diffuse out of speckles into the nucleoplasm, so AQR is not merely resident in speckles but contributes to retaining a transcript there (PMID 22355166, where it appears under its former name IBP160). This is the observation behind UniProt's uncoded 'speckle-like regions' note. (2) PROMOTER-PROXIMAL CHROMATIN: native chromatin proteomics places AQR in ECAS, a bipartite assembly joining an AFF4-ELL2-EAF1 elongation module to a U2 snRNP-associated intron binding complex, which OCCUPIES PROMOTER-PROXIMAL CHROMATIN and is reported as molecularly distinct from the canonical P-TEFb-containing SEC (PMID 42748909, already cited in this entry).",
  "why_two_addresses_is_the_right_answer": "A speckle is a storage and assembly compartment for splicing factors and a promoter-proximal chromatin site is where co-transcriptional processing happens. For a protein that couples splicing to elongation, having both is the expected and informative answer, and a single 'nucleoplasm' call - which is what HPA reports and what an asynchronous antibody image gives - resolves neither.",
  "how_shown": "RNAi depletion with RNA-FISH for MALAT-1 relocalisation (PMID 22355166); native chromatin proteomics with acute degradation and nascent-transcription readouts (PMID 42748909); HPA antibody IF",
  "node": "localization-nuclear-speckles-kmt2a-r"
}
cell type
{
  "haematopoietic_answer": "MOUSE HAEMATOPOIETIC CELLS, functionally and not by imaging - this entry already records that Aqr perturbation impairs leukaemia initiation, maintenance and leukaemia stem cell function in MLL-rearranged leukaemia in mouse haematopoietic cells, with the fusion partner not named in the abstract. No AQR localisation experiment has been done in any haematopoietic cell: the speckle work is in HeLa-class human lines and the ECAS chromatin proteomics is in human cells that are not leukaemic.",
  "expression_atlas": "HPA v25.1: RNA tissue specificity Low; IF reliability Enhanced (nucleoplasm)."
}
ecas is not in the fusion interactome
{
  "_added": "king, cycle 48, 2026-09-21, after testing it",
  "tested": "Whether ECAS -- the assembly this entry places AQR in -- appears in Skucha's 960-protein MLL-fusion interactome (PMID 29777171).",
  "result": "It does not. AQR is ABSENT from the 960. ELL2 and EAF1, the other two members of ECAS's elongation module, are also absent. Of the eight intron-binding-complex components only BUD13 and XAB2 appear, and neither is in the MLL-AF4 column.",
  "so_what": "AQR's ECAS membership and its promoter-proximal chromatin occupancy are supported by PMID 42748909 and are not weakened by this. But there is NO evidence from the fusion interactome that AQR or ECAS contacts a KMT2A fusion protein, and the adjacency of 'ECAS occupies promoter-proximal chromatin' to 'the fusion drives elongation' should not be read as a physical connection. The canonical SEC is 7 of 8 in that same network, all in the MLL-AF4 column, so the dataset had every chance to find an elongation assembly and found the other one."
}
How this could bite us back
  • AQR is core spliceosomal machinery. Any intervention risks the same therapeutic-window failure that has dogged spliceosome-directed agents, and the abstract offers no evidence of a leukaemia-selective window.
  • The long-gene bias is a confound as much as a mechanism: a perturbation that preferentially damages long genes will damage many essential long genes, and 'leukaemia stem cells are more sensitive' may reflect proliferation rate rather than fusion biology.
Still open
  1. ANSWERED 2026-09-19, unfavourably: AQR ranks 17,654/17,728 in the genome-wide scan, on the less-required side. The live question is now whether that is a floor effect on a strongly pan-essential gene, or a real absence of cell-autonomous selectivity - which an essentiality-matched null would separate.
  2. Is the AQR requirement KMT2A-fusion-selective, or does it hold across leukaemia stem cells generally? The abstract does not compare.
  3. Does ECAS survive an orthogonal separation from SEC on the same chromatin, or is it a state of SEC rather than a distinct assembly?
  4. AQR loss preferentially affects long genes. KMT2A is 3,969 aa and among the longest genes in the relevant programme - is the effect on KMT2A-fusion leukaemia partly a gene-length effect on the fusion's own targets?
Every source behind this entry (4)
  1. E1moderate confidence 3 of 5: One strong study, or several smaller consistent ones.paper

    Native chromatin proteomics in human cells identifies ECAS, a bipartite assembly linking an AFF4-ELL2-EAF1 elongation module to a U2 snRNP-associated intron binding complex, occupying promoter-proximal chromatin and molecularly distinct from canonical P-TEFb-containing SEC. Acute perturbation of AQR/XAB2-dependent ECAS functions impairs productive gene-body elongation without altering pause release, increases intron retention and preferentially affects long genes. In mouse haematopoietic cells Aqr is highly expressed and its perturbation impairs leukaemia initiation, maintenance and leukaemia stem cell function in MLL-rearranged leukaemia.

    A dual-module ECAS complex couples transcription elongation and RNA processing · Xiang Y, Wang H, Yin Z, et al. (Liang K, senior author) · Molecular Cell, online ahead of print 16 September 2026 2026
    What this evidence cannot show

    Read as abstract only; online ahead of print. The leukaemia phenotype is reported in MOUSE haematopoietic cells and described as 'MLL-rearranged' without the abstract naming the fusion partner, the model, or whether any human KMT2A::AFF1 material was used. 'Profoundly impairs' is the authors' wording and is not quantified in the abstract. Acute perturbation of a spliceosomal RNA helicase has wide consequences, so a leukaemia-selective window is not established by these data.

    Evidence that argues against this (1)
    • The claim that ECAS is distinct from SEC is a proteomics result about a chromatin-associated assembly, and assemblies sharing AFF4 and ELL2 are hard to resolve from one another by purification - this is the same class of inference that produced the 2004-2012 affinity-purification picture this project already treats as provisional. Until an orthogonal method separates ECAS from SEC on the same chromatin, 'distinct complex' and 'distinct state of one complex' are not discriminated. Xiang Y et al. 2026
  2. E2established confidence 5 of 5: Multiple independent lines of evidence; treated as settled in the field.database

    UniProtKB O60306 (AQR_HUMAN), RNA helicase aquarius, primary gene name AQR, 1,485 aa.

    What this evidence cannot show

    Resolved by the coordinator on 2026-09-19 via gene_exact:AQR with reviewed:true, and the PRIMARY gene name read back rather than the query term - this project has twice been caught by a synonym resolving to the wrong protein (TCF3 to TCF7L1) or a stale symbol (WDR61 to SKIC8).

    Evidence that argues against this (1)
    • A UniProt header record gives the accession, the symbol and the length, and nothing about whether the protein does anything in this disease. For a 1,485-residue RNA helicase, the length is the least informative fact available. UniProt Consortium 2026
  3. E_depmap_rankmoderate confidence 3 of 5: One strong study, or several smaller consistent ones.database

    DepMap does not support AQR as a KMT2A-rearranged-selective dependency, and points the other way. In the genome-wide scan of 17,728 genes, AQR ranks 17,654 (99.58th percentile) with a difference of +0.244 - i.e. KMT2A-rearranged lines need AQR LESS than other leukaemia lines, not more. Its ECAS partner XAB2 is more extreme still at rank 17,704 (+0.324). For contrast, in the same scan MEN1 ranks 1, KMT2A 11, MEIS1 84, AFF1 160, DOT1L 184 and USP22 226.

    Genome-wide KMT2A-rearranged selectivity scan, 17,728 genes (DepMap Chronos via Open Targets) · Broad Institute DepMap / Open Targets Platform; analyses/depmap-kmt2a-selective-scan-full 2026
    What this evidence cannot show

    Computed by the coordinator on 2026-09-19 over 11 KMT2A-rearranged and 43 other leukaemia lines. AQR and XAB2 are strongly pan-essential (mean gene effect -1.15 and -2.31), and a difference statistic is least informative where everything dies: a floor effect can compress or invert the sign. This project's own essentiality-confound analysis found essentiality explains only 0.4% of variance ACROSS the scan, but that average does not license reading the extreme tail, which is exactly where AQR sits. None of the eleven rearranged lines is infant-derived.

    Evidence that argues against this (1)
    • The assay cannot see the phenotype the ECAS paper reports. That result is leukaemia INITIATION, MAINTENANCE and leukaemia stem cell function in mouse haematopoietic cells in vivo; DepMap measures proliferation of established human cell lines in culture, where self-renewal is not a readout and no stem compartment exists. A gene required for LSC function and dispensable for bulk proliferation would look exactly like this. So the scan weakens the case for AQR as a cell-autonomous KMT2A-r-selective vulnerability without touching the claim actually made. Xiang Y et al. 2026
  4. E3moderate confidence 3 of 5: One strong study, or several smaller consistent ones.paper

    AQR's speckle address is functional, not merely positional: RNAi depletion of the nuclear speckle proteins RNPS1, SRm160 or IBP160 - IBP160 being AQR under its former name - causes the MALAT-1 noncoding RNA to diffuse out of nuclear speckles into the nucleoplasm, so these proteins contribute to retaining MALAT-1 in the compartment. This is the observation behind UniProt O60306's uncoded note that AQR 'localizes to speckle-like regions of the nucleoplasm'.

    Identification of cis- and trans-acting factors involved in the localization of MALAT-1 noncoding RNA to nuclear speckles. · Miyagawa R, Tano K, Mizuno R, Nakamura Y, Ijiri K, Rakwal R, et al. · RNA 2012
    What this evidence cannot show

    AQR appears here under the retired name IBP160 and is one of three proteins tested, so the result is about a shared speckle function rather than an AQR-specific address; the paper's subject is MALAT-1, not AQR. HeLa-class human cells, RNAi, no haematopoietic system and no fusion. Note the search hazard: 'speckle*' is 40% echocardiography and related imaging noise in PubMed (data/symbol-collisions.json), so this literature has to be reached with the quoted phrase.

    Evidence that argues against this (1)
    • A speckle-only answer would put AQR in the wrong place for everything this graph uses it for. Native chromatin proteomics puts AQR in ECAS, an assembly that OCCUPIES PROMOTER-PROXIMAL CHROMATIN and joins a U2 snRNP-associated intron binding complex to an AFF4-ELL2-EAF1 elongation module - and is explicitly reported as molecularly DISTINCT from the canonical P-TEFb-containing SEC. Nuclear speckles are where splicing factors are stored and assembled; promoter-proximal chromatin is where AQR's measured phenotype occurs, since acute perturbation impairs gene-body elongation without altering pause release. The two addresses are not in conflict, but the speckle one is the less informative of the two for a fusion graph, and an entry recording only it would obscure that AQR sits beside AFF4. Xiang Y et al. 2026
Connected to